Changes needed to ensure corporate interest don’t prevail: insiders say publicly that Canadian Food Inspection Agency management “cares little aobut food safety, about science, about the public”
In the public debate over biotechnology, Parliamentarians need to ask two basic questions. Both surfaced during the Senate inquiry into recombinant bovine somatotropin (rBST), the first genetically-engineered drug to reach Health Canada regulators -- and a drug that was not allowed on the market....
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
